Interpretable multi-omics machine learning reveals unexpected drug mechanisms in Huntington disease models
An interpretable machine-learning model integrated transcriptomic, epigenomic, metabolomic and proteomic data from Huntington-disease cell models to identify previously unknown mechanisms for protective compounds. The analysis predicted autophagy activation for one compound group and mitochondrial-respiration inhibition for another; follow-up imaging, biochemical and energetics assays experimentally confirmed these effects in the cell model.
Technology: Interpretable network-optimization model integrating multi-omics over a molecular-interaction network
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: The analysis predicted autophagy activation for one compound group and mitochondrial-respiration inhibition for another; follow-up imaging, biochemical and energetics assays experimentally confirmed these effects in the cell model.
- Still unknown: Findings were experimentally established in STHdhQ111 murine striatal cells, with autophagy effects also checked in human SH-SY5Y and HEK293 cell lines. The paper notes that the model prioritizes pathways but does not resolve every causal step or demonstrate therapeutic efficacy in patients.
- AI role: The model integrated multiple omics and prioritized cellular pathways as candidate mechanisms of action; researchers tested those predictions with cellular imaging, biochemical assays and energetics measurements. It revealed unexpected mechanisms for compounds with unrelated known targets.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC6976599/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 76 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.